PGNY | ProgynyNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$29.06
-$0.35 (-1.19%)

Progyny (PGNY) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $29.06 vs 50 $27.03 / 200 $24.41
Projection
No cross projected
Test
No active test
Last cross
Golden cross 18 Jun 2026 ยท projected 26 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $29.55 vs 50 $27.57 / 200 $28.04
Projection
Golden cross projected in 6 bars
Test
No active test
Last cross
Death cross 11 Sep 2026 ยท projected 28 bars out

Cross history

26
crosses on record since 2022
13 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
11 Sep 2026Death4-hour28 bars outNot tested
18 Jun 2026Golden steepdaily26 bars outNot tested
26 May 2026Golden4-hour28 bars outNot tested
12 Mar 2026Death steepdaily28 bars outNot tested
19 Feb 2026Death4-hour25 bars outNot tested

About PGNY

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$25.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.